1. The researchers added carbonic anhydrase genes to plants that do not react to higher levels of carbon dioxide.
这些研究者将碳酸酐酶基因编入到那些对高二氧化碳浓度没有反应的植物中。

来自互联网

2. Objective: To investigate the effect of metabolic acidosis on carbonic anhydrase (ca) activity in rat erythrocytes.
目的:探讨代谢性酸中毒对大鼠红细胞碳酸酐酶(ca)活性的影响。

来自互联网

3. Thus, systemic acidosis or the other side effects associated with oral carbonic anhydrase inhibitors are not expected to occur.
因此,不会出现全身酸中毒或其他与口服碳酸酐酶抑制剂有关的副作用。

来自互联网

4. Carbonic anhydrase(CA; EC 4.2.1.1)is a zinc-containing metalloenzyme that catalyzes the reversible conversion of CO_2 to bicarbonate.
碳酸酐酶是催化二氧化碳的可逆水合反应的一种含锌金属酶。

来自互联网

5. Aim: To clone the cross-intron genomic DNAs of the duplicated carbonic anhydrase (DCA1) and carbonic anhydrase (CA1) genes from Dunaliella salina.
目的:克隆杜氏盐藻双拷贝碳酸酐酶(DCA1)和碳酸酐酶(CA1)基因跨内含子基因组dna序列。

来自互联网

6. The activity of carbonic anhydrase in the soils of low vegetation coverage is lower than that in the soils of high vegetation coverage in various Karst ecosystems.
对于不同岩溶生态系统,植被覆盖率低的土壤碳酸酐酶活性低于植被种类丰富的土壤碳酸酐酶活性。

来自互联网

7. Carbonic anhydrase is a ubiquitous metal enzyme existed in organism which can catalyze the reversible hydration reaction of CO2. Microorganism is an important source of carbonic anhydrase.
碳酸酐酶是生物体中普遍存在的一种金属酶,能催化CO2可逆的水合反应,微生物是碳酸酐酶的重要来源之一。

来自互联网

8. The compound has favorable suppressive activity of carbonic anhydrase, stronger hydrophilicity and little collection and little nonspecific absorption in a digestive system of a human body.
本发明的化合物具有较好的碳酸酐酶抑制活性,且具有较强的亲水性,在人体消化系统内的浓集少,非特异性吸收少。

来自互联网

9. Carbonic anhydrase inhibitors (CAIs) were first used to lower intraocular pressure (IOP) in glaucoma in 1954, with the introduction of acetazolamide, methazolamide and diclofenamide were subsequently.
乙酰唑胺、醋甲唑胺、双氯非那胺等碳酸酐酶抑制剂自1954年起就被应用于青光眼的降眼压治疗。

来自互联网

10. Carbonic anhydrase inhibitors (CAIs) were first used to lower intraocular pressure (IOP) in glaucoma in 1954, with the introduction of acetazolamide, methazolamide and diclofenamide were subsequently.
乙酰唑胺、醋甲唑胺、双氯非那胺等碳酸酐酶抑制剂自1954年起就被应用于青光眼的降眼压治疗。

来自互联网